CytomX Therapeutics Inc. logo

CytomX Therapeutics Inc.

CTMX | NASDAQ
Chart Builder DCF Calculator
$2.79
+$0.03 (+1.09%)
Sep 22, 2026, 11:18 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
12.67M 38.05M 17.17M 193.65M 205.53M 191.86M
Short-Term Investments
124.39M 62.57M 157.34M n/a 99.7M 124.26M
Long-Term Investments
n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
1.56M 1.09M 1M 944K 1.82M 3.09M
Receivables
2.01M 3.1M 3.43M 35.99M 790K 798K
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
4.86M 3.58M 5M 7.47M n/a n/a
Total Current Assets
143.92M 107.31M 182.94M 237.1M 310.3M 324.01M
Property-Plant & Equipment
4.7M 10.6M 16.18M 21.02M 25.32M 29.45M
Goodwill & Intangibles
1.39M 1.53M 1.68M 1.82M 1.97M 2.12M
Total Long-Term Assets
7.65M 13.23M 18.86M 23.79M 29.11M 34.65M
Total Assets
151.57M 120.53M 201.79M 260.89M 339.41M 358.66M
Account Payables
1.3M 1.09M 1.46M 2.81M 2.82M 3M
Deferred Revenue
26.88M 67.2M 132.27M 121.27M 40.82M 42.06M
Short-Term Debt
4.24M n/a n/a n/a n/a n/a
Other Current Liabilities
5.99M n/a 9.44M n/a n/a n/a
Total Current Liabilities
46.62M 85.77M 155.91M 152.61M 77.87M 68.11M
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
4.35M 4.12M 3.89M n/a n/a n/a
Total Long-Term Liabilities
5.94M 35.22M 93.33M 194.03M 262M 298.33M
Total Liabilities
52.56M 120.99M 249.24M 346.64M 339.87M 366.44M
Total Debt
4.24M 9.39M 13.97M 18.06M 21.67M 24.87M
Book Value
99.01M -456K -47.45M -85.75M -459K -7.77M
Book Value Per Share
0.72 -0.01 -0.64 -1.30 -0.01 -0.17
Common Stock
2K 1K 1K 1K 1K 1K
Retained Earnings
-711.95M -691.58M -723.45M -722.88M -623.56M -507.69M
Comprehensive Income
111K 27K 95K 10K -242K -47K
Shareholders Equity
99.01M -456K -47.45M -85.75M -459K -7.77M
Total Investments
124.39M 62.57M 157.34M n/a 99.7M 124.26M

© 2026 bestshares.com. All rights reserved.